30-7503US tTg-A (FDA cleared)

Intended Use:

The AESKULISA tTg-A New generation is a solid phase enzyme immunoassay for the quantitative and qualitative detection of antibodies against neo-epitopes of tissue transglutaminase (tTG) in human serum.

Recombinant Antigens:

Tissue transglutaminase (neo-epitopes), Cross-linked with specific peptides of gliadin

Native Antigens:

n.a.

Kit Configuration

Type: AESKULISA®
Method: Elisa
Reference: 30-7503US
Description: tTg-A (FDA cleared)
Kit Configuration: Single - A
Cut Off: 15
Range: 0 - 300 U/ml
Standard: -
Antibodies: IgA

Downloads